Stryker (NYSE:SYK) Posts Q3 Sales In Line With Estimates
Update: 2025-10-30
Description
Stryker, a leading medical technology company, reported Q3 results that met Wall Street expectations, with sales up 10.2% to $6.06 billion and adjusted earnings per share at $3.19, a 1.9% increase. Despite a slight dip in operating and free cash flow margins, Stryker's strong brand and steady sales growth position it well in the competitive healthcare tech market. While investors hoped for more, analysts still predict nearly 9% revenue growth over the next year.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
